48 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
items excluded from non-GAAP EPS.
5 Progressing our ESG Strategy and Health Equity Initiatives INCLUSION & DIVERSITY Executive representation
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
8 Jan 24
Regulation FD Disclosure
10:29am
and Inclusion & Diversity Climate Change & Emissions Public Health & Public Policy Breakdown:Top ESG Issues by Theme Looking Ahead Evolved ESG
8-K
EX-99.1
xcrk4jcb5
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
o8k2lwiq3p0wxf
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
jb7wblj tndno62
26 Apr 23
Additional proxy soliciting materials
4:38pm
8-K
EX-99.1
pjivsj
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
DEFA14A
k9o f5xsmt
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
ckeqcabrhv4mhpy
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
xolvaxpcy8z1
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
EX-99.3
lfjbaxttnfoym
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
21e1dzabtrt ho1
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.3
mvu8g7umoovmlpj9mi
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.1
33rue4omze jo3ltlz
16 Nov 21
Regulation FD Disclosure
9:20am
8-K
EX-99.1
10nps6rjonen0h
27 Oct 21
Bristol Myers Squibb Reports Third Quarter Financial Results for 2021
9:46am
8-K
EX-99.1
nd9dzep9vd6zds mde
29 Apr 21
Bristol Myers Squibb Reports First Quarter Financial Results for 2021
8:38am